Aurigene is a clinical stage biotech company founded in 2002, dedicated to discovering and developing innovative therapeutics for the treatment of cancer. With a deep expertise in oncology, Aurigene is committed to making a significant impact in the lives of cancer patients worldwide. They focus on addressing various hallmarks of cancer through the development of novel and effective therapies.

Their approach involves building collaborations with leading companies globally and leveraging their extensive scientific capabilities. Over the past two decades, Aurigene has established a comprehensive drug discovery and development infrastructure, and currently has 19 programs in global clinical development. With a team of over 425 passionate scientists, they have successfully conducted over 80 integrated drug discovery projects and hold more than 200 NCE patents.

Stay updated with Aurigene's latest advancements through their media center and explore their vast body of work in oncology research, innovative technology, and therapeutics. Apply now to be a part of their dedicated team and join them in their mission to conquer cancer